Future treatments for hereditary hemorrhagic telangiectasia | Orphanet Journal of Rare Diseases | Full Text

Future treatments for hereditary hemorrhagic telangiectasia | Orphanet Journal of Rare Diseases | Full Text

Future treatments for hereditary hemorrhagic telangiectasia

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Rendu-Osler syndrome, is a genetic vascular disorder affecting 1 in 5000–8000 individuals worldwide. This rare disease is characterized by various vascul...

Authors:Florian Robert, Agnès Desroches-Castan, Sabine Bailly, Sophie Dupuis-Girod and Jean-Jacques Feige

Citation:Orphanet Journal of Rare Diseases 2020 15:4

Content type:Review

Published on: 7 January 2020

• ViewFull Text
 
• ViewPDF